A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Clinical trial NCT01994291 · TERMINATED
Trial details
- NCT number
- NCT01994291
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2015-08-01
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.